Page URL:

New consumer law guidelines for IVF sector

17 February 2020
Appeared in BioNews 1035

The UK Competition and Markets Authority (CMA) will create consumer protection guidelines for the UK fertility sector, to ensure that IVF clinics practice in accordance with consumer law. 

The CMA will work in conjunction with the fertility sector regulator, the Human Fertilisation and Embryology Authority (HFEA), and the Advertising Standards Authority (ASA) to review the current practice of IVF clinics within the UK and to devise a set of working guidelines that promote the fair treatment of fertility patients. This guidance will also ensure that clinics know what their legal obligations are in terms of consumer protection. 

'The Competition and Markets Authority has concerns about possible cases of mis-selling of services such as IVF 'add-on' treatments, and possible misrepresentation of clinics' success rates… Going through or exploring potential fertility treatments can be a stressful and emotional experience, with people having to make decisions in challenging circumstances. As such, it is important that clinics provide all the necessary information on treatments to allow patients to make informed choices,' they announced.

The planned guidelines will focus on four areas: transparency of treatment costs; how treatment 'add-ons' are advertised and sold to patients; the accuracy of success rates and the format in which they are presented to patients, as well as the general terms and conditions of fertility treatment.

The CMA want clinics to present their patients with 'clear and upfront prices for their treatments' and will seek to ensure that patients are 'given all the information they need before deciding whether an add-on is right for them'. 

The announcement follows concerns expressed by the HFEA (see BioNews 1015) and other organisations that some patients are potentially being mis-sold unnecessary 'add-ons' that can increase treatment costs by thousands of pounds. 

The ASA, the UK's independent regulator of advertising, will focus on how fertility clinics advertise their services, and in particular, how they present their success rates. 

At present, it is unclear whether any of the UK fertility clinics are in breach of the current consumer protection law. However, the CMA has warned that 'enforcement action' could be implemented if the review committee identifies any deliberate misleading practice.

A draft version of the fertility sector guidance is expected to be published in July 2020 and will undergo a public consultation. The CMA intends to draw upon first-hand experiences to shape their consumer law guidelines and want to hear from patients who believe their fertility treatment was misrepresented or mis-sold. The finalised guidelines are expected to be published by the end of 2020. 

Sarah Norcross, director of the Progress Educational Trust (the charity that publishes BioNews) told the Mail: 'This can only be good news for fertility patients, who typically have to make multiple decisions about very costly options while deeply distressed and vulnerable.'

CMA to issue consumer law guidelines for the IVF sector |  7 February 2020
Competition watchdog probes rip-off IVF clinics 'that are exaggerating success rates and mis-selling treatments to desperate couples'
Daily Mail |  7 February 2020
Launch of new project by the competition and markets authority into the IVF sector
Human Fertilisation and Embryology Authority |  7 February 2020
New guidelines for the IVF sector
ASA |  7 February 2020
What IVF providers can expect from the CMA's review
Pinset Masons |  13 February 2020
25 January 2021 - by BioNews 
This film documents a Progress Educational Trust event about consumer protection for fertility patients...
16 November 2020 - by Debbie Kitcher-Jones 
Consumer law gives important protections to fertility patients, as it does consumers in other markets. The CMA has provided guidance to help clinics providing fertility treatment to patients in the UK understand and comply with their existing obligations under consumer law...
9 November 2020 - by Martha Roberts 
The UK Competition and Markets Authority has released draft guidance for the UK fertility sector, to ensure IVF clinics understand and comply with consumer law...
7 July 2020 - by Dr Catherine Hill 
Couples undergoing fertility treatment markedly overestimate their chance of IVF success, men to a greater extent than women, according to new research...
11 May 2020 - by Dr Jennifer Frosch 
Women who used fertility treatment to conceive their first child have a good chance of having a second child the same way, according to a new study...
3 February 2020 - by Fiona Duffy 
I reflect with sadness on the slow pace of progress in legislating for assisted human reproduction (AHR) in Ireland. This is all the more poignant when I read the good news coming from France and the recent Court decisions on the recognition of parentage for children born through surrogacy...
16 September 2019 - by Rikita Patel 
The UK fertility regulator, the HFEA, has called for reforms in the way fertility add-on treatments are offered to patients, according to a consensus statement...
4 February 2019 - by Dr Kamal Ahuja and Professor Nick Macklon 
Recently, the HFEA released a statement on adjunct treatments in IVF. The regulator had provided clear notice of its publication and both its stated intentions and content were as anticipated...
21 January 2019 - by Rikita Patel 
The Human Fertilisation and Embryology Authority has published a final consensus statement advising that IVF clinics should not charge patients for add-on treatments that are not proven effective by clinical trials...
17 December 2018 - by Ewa Zotow 
Sixty-two percent of private IVF patients paid 'more than they expected' for treatment, according to the first national patient survey by the HFEA.
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.